Sabril Powder, For Solution
NDC Package 67386-211-65
Package Information
Sabril (vigabatrin) powders is vigabatrin is used to treat babies, one month to 2 years old who have a condition known as infantile spasms. This formulation utilizes a powder, for solution delivery system. Marketed by Lundbeck Pharmaceuticals Llc, this product is identified by NDC 67386-211 and is authorized under FDA application NDA022006.
Identification & Billing
- RxCUI: 250820 - vigabatrin 500 MG Powder for Oral Solution
- RxCUI: 860898 - Sabril 500 MG Powder for Oral Solution
- RxCUI: 860898 - vigabatrin 500 MG Powder for Oral Solution [Sabril]
- RxCUI: 860898 - Sabril 50 MG/ML (500 MG packet) Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67386 - Lundbeck Pharmaceuticals Llc
- 67386-211 - Sabril
- 67386-211-65 - 50 PACKET in 1 CARTON / 10 mL in 1 PACKET
- 67386-211 - Sabril
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67386-211-65 identifies a specific commercial package of 50 packet in 1 carton / 10 ml in 1 packet of Sabril, a human prescription drug labeled by Lundbeck Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This powder, for solution is formulated for oral use and contains vigabatrin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lundbeck Pharmaceuticals Llc on August 21, 2009. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Vigabatrin is used to treat babies, one month to 2 years old who have a condition known as infantile spasms. Vigabatrin has also been used in combination with other medications to treat seizure disorders (epilepsy). Vigabatrin decreases the number of seizures in adults and children who have not been able to control their seizures with other treatment. Vigabatrin is an anticonvulsant. It is thought to work by stopping the breakdown of a natural calming substance (GABA) in the brain.
How is this Lundbeck Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67386021165. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.